FDA Inspection
John Kumar Jain MD Inc.John Kumar Jain MD Inc. – FDA Inspection, Feb 8, 2019
Record Details
This FDA Inspection record concerns John Kumar Jain MD Inc., with an inspection on February 8, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c0ec8beb-2399-43ec-ae54-459796af664a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1079897
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
Other FDA inspections of John Kumar Jain MD Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 2, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 23, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 20, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 2, 2009 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for John Kumar Jain MD Inc.
- FDA Inspection 1222754 - 2023-11-02
- FDA Inspection 987194 - 2016-09-23
- FDA Inspection 795837 - 2012-08-20
- FDA Inspection 611636 - 2009-09-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.